IDO expression by dendritic cells: Tolerance and tryptophan catabolism
- Andrew L. Mellor(corresponding author),
Scholary Output:
Contribution to journal
Review article
Peer-reviewAbstract
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that degrades the essential amino acid tryptophan. The concept that cells expressing IDO can suppress T-cell responses and promote tolerance is a relatively new paradigm in immunology. Considerable evidence now supports this hypothesis, including studies of mammalian pregnancy, tumour resistance, chronic infections and autoimmune diseases. In this review, we summarize key recent developments and propose a unifying model for the role of IDO in tolerance induction.
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 762-774 (13 pages)Journal (Volume, Issue Number)
Nature Reviews Immunology (Volume 4, Issue 10)Publication milestones
- Published - 10/2004
Publication status
Published - 10/2004
ISSN
1474-1733Publication IDs
- Scopus: 5044220930
- PubMed: 15459668
Publication metrics
Metrics
SciVal
FWCI
13.02
SciVal
Author count
2
SciVal
citations
1703
SciVal
Paper percentile
99
SciVal
Top percentile
1
Fractional count
2
Fractional count
1
Fractional count
2
Fractional count
1
PlumX, opens in new tab
Captures
1075
Citation count
2125
Mentions
2
Funding Details
We acknowledge the National Institutes of Health for supporting the research described in this review.
